168 related articles for article (PubMed ID: 9892304)
1. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
Rabkin JG; Wagner GJ; Rabkin R
Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
3. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Harrison W; Wagner G
Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ
Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
[TBL] [Abstract][Full Text] [Related]
6. Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial.
Rabkin JG; Wagner GJ; McElhiney MC; Rabkin R; Lin SH
J Clin Psychopharmacol; 2004 Aug; 24(4):379-85. PubMed ID: 15232328
[TBL] [Abstract][Full Text] [Related]
7. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant treatment of depression in HIV-seropositive women.
Ferrando SJ; Rabkin JG; de Moore GM; Rabkin R
J Clin Psychiatry; 1999 Nov; 60(11):741-6. PubMed ID: 10584761
[TBL] [Abstract][Full Text] [Related]
11. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
[TBL] [Abstract][Full Text] [Related]
12. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
13. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ
J Clin Psychiatry; 2010 Jun; 71(6):707-15. PubMed ID: 20492840
[TBL] [Abstract][Full Text] [Related]
14. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
[TBL] [Abstract][Full Text] [Related]
15. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
Rabkin JG; Wagner G; Rabkin R
J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine treatment of dysthymia in the elderly.
Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
